Lunai Bioworks Issues Shareholder Letter, Distributed as Press Release

What Happened

• Lunai Bioworks, Inc. announced in an 8-K that it issued a letter to shareholders that was distributed as a press release on June 17, 2026. The company stated it may use the letter and information from it, with possible modifications, in future presentations to investors, analysts, lenders, partners, acquisition candidates, customers, employees and others. A copy of the letter is available on the company’s investor website at ir.lunaibioworks.com. The company clarified that website materials are not part of or incorporated by reference into the 8-K.

Key Details

• Date of disclosure: June 17, 2026.
• Communication type: Letter to shareholders distributed as a press release and posted on the company’s investor website.
• Reuse notice: Company may reuse the letter’s content (possibly modified) in future investor and stakeholder presentations.
• Website materials are explicitly not incorporated by reference into the filing.

Why It Matters

• This is an investor communications update: the company is proactively sharing information with shareholders and other stakeholders.
• The reuse notice means the language in the letter could appear in future investor presentations or materials, so investors should review the posted letter for any strategic, operational, or financial context the company is emphasizing.
• Because the materials on the website are not incorporated by reference, the filing preserves the company’s legal boundaries for disclosure while still making the information widely available.